Since there is a known inhibitor of SOAT1, mitotane, we finally selected and validated the anti-cancer effect of SOAT1 in a widely used ccRCC cell line Caki-1. The gene discussed is SOAT1; the disease is nonpapillary renal cell carcinoma.